199 related articles for article (PubMed ID: 32063274)
1. Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites.
Uehara T; Yoshida H; Fukuhara M; Yoshida M; Motoi N; Sugawara S; Sone M; Arai Y; Tamura K; Uno M; Ishikawa M; Kato T
Gynecol Oncol; 2020 May; 157(2):398-404. PubMed ID: 32063274
[TBL] [Abstract][Full Text] [Related]
2. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of Carcinoembryonic Antigen in Ascites for Colorectal Cancer with Peritoneal Carcinomatosis.
Song SE; Choi P; Kim JH; Jung K; Kim SE; Moon W; Park MI; Park SJ
Korean J Gastroenterol; 2018 Jun; 71(6):332-337. PubMed ID: 29943560
[TBL] [Abstract][Full Text] [Related]
4. The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma.
Saygili U; Guclu S; Uslu T; Erten O; Dogan E
Int J Gynecol Cancer; 2002; 12(5):438-42. PubMed ID: 12366659
[TBL] [Abstract][Full Text] [Related]
5. Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology.
Gulyás M; Kaposi AD; Elek G; Szollár LG; Hjerpe A
J Clin Pathol; 2001 Nov; 54(11):831-5. PubMed ID: 11684715
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination.
Emoto S; Ishigami H; Yamashita H; Yamaguchi H; Kaisaki S; Kitayama J
Gastric Cancer; 2012 Apr; 15(2):154-61. PubMed ID: 21892754
[TBL] [Abstract][Full Text] [Related]
7. CEA in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.
Sagi-Dain L; Lavie O; Auslander R; Sagi S
Int J Biol Markers; 2015 Nov; 30(4):e394-400. PubMed ID: 26109367
[TBL] [Abstract][Full Text] [Related]
8. Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin.
Stiekema A; Boldingh QJ; Korse CM; van der Noort V; Boot H; van Driel WJ; Kenter GG; Lok CA
Gynecol Oncol; 2015 Mar; 136(3):562-6. PubMed ID: 25560808
[TBL] [Abstract][Full Text] [Related]
9. Is ascites CEA a risk factor for peritoneal carcinomatosis in colorectal cancer?: a long-term follow-up study.
Kim BC; Bae JH; Park SM; Won DY; Lee IK
Int J Colorectal Dis; 2020 Jan; 35(1):147-155. PubMed ID: 31802190
[TBL] [Abstract][Full Text] [Related]
10. CA125, CEA, CA19-9, and Heteroploid Cells in Ascites Fluid May Help Diagnose Peritoneal Carcinomatosis in Patients with Gastrointestinal and Ovarian Malignancies.
Deng L; Guo S; Li H; You X; Song Y; Su H
Cancer Manag Res; 2020; 12():10479-10489. PubMed ID: 33122947
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma.
Na K; Lee JY; Sung JY; Kim GM; Koo JS; Kim HS
Virchows Arch; 2018 Aug; 473(2):165-175. PubMed ID: 29926183
[TBL] [Abstract][Full Text] [Related]
12. The significance of the pattern of serum CA125 level ascent to above the normal range in epithelial ovarian, primary peritoneal and tubal carcinoma patients.
Levy T; Weiser R; Boaz M; Ben Shem E; Golan A; Menczer J
Gynecol Oncol; 2013 Apr; 129(1):165-8. PubMed ID: 23274778
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological analysis and differential diagnosis of primary peritoneal adenocarcinoma].
Gong HL; Wang CB; Zhang GJ; Li CF; Yang XY; Hou HL; Zhang XB
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):463-5. PubMed ID: 19567094
[TBL] [Abstract][Full Text] [Related]
14. [Study of apoptosis and Fas expression of peritoneal fluid and peripheral blood T lymphocytes in patients with epithelial ovarian cancer and their relationship with CA125].
Ma YX; Ye F; Chen HZ; Lü WG; Xie X
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):734-9. PubMed ID: 17565840
[TBL] [Abstract][Full Text] [Related]
15. [Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125].
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Stabile Ianora AA; Giganti M; Niccoli Asabella A
Recenti Prog Med; 2012 Nov; 103(11):510-4. PubMed ID: 23096741
[TBL] [Abstract][Full Text] [Related]
16. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
[TBL] [Abstract][Full Text] [Related]
17. Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer.
Muallem MZ; Sehouli J; Richter R; Babayeva A; Gasimli K; Parashkevova A
Int J Gynecol Cancer; 2020 Jan; 30(1):62-66. PubMed ID: 31744887
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy.
Huo YR; Huang Y; Liauw W; Zhao J; Morris DL
Anticancer Res; 2016 Mar; 36(3):1041-9. PubMed ID: 26976996
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.
Fujimura T; Kinami S; Ninomiya I; Kitagawa H; Fushida S; Nishimura G; Kayahara M; Shimizu K; Ohta T; Miwa K
Endoscopy; 2002 Jul; 34(7):569-74. PubMed ID: 12170412
[TBL] [Abstract][Full Text] [Related]
20. Is cell block technique useful to predict histological type in patients with ovarian mass and/or body cavity fluids?
Maseki Z; Kajiyama H; Nishikawa E; Satake T; Misawa T; Kikkawa F
Nagoya J Med Sci; 2020 May; 82(2):225-235. PubMed ID: 32581403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]